E. N. van den Brink

发表

DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies

P. Parren, Laurens P. Kil, B. van Kessel, 2020, Blood Cancer Journal.

IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP.

J. Flier, R. Willemze, D. Boorsma, 1999, Cytokine.

The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

J. T. ten Cate, J. V. van Mourik, J. Voorberg, 1997, Blood.

Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain.

J. Voorberg, K. Fijnvandraat, C. Bank, 2000, Blood.

Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors

P. LoRusso, E. Stanganello, U. Şahin, 2022, Cancer discovery.

Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes.

W. Ouwehand, J. Voorberg, N. Bovenschen, 2000, Blood.

Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII.

T. Ortel, J. Voorberg, N. Bovenschen, 2002, Blood.

Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII.

J. Voorberg, N. Bovenschen, K. Mertens, 2001, Blood.

Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants

Jaap Goudsmit, Wolfgang Preiser, Johannes A Bogaards, 2006, PLoS medicine.

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

T. Kuiken, B. Haagmans, A. Osterhaus, 2004, The Lancet.

Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus

H. Doerr, A. Osterhaus, W. Preiser, 2005, Journal of Virology.

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models

T. Plantinga, K. Kemper, M. Houtkamp, 2022, Life Science Alliance.

DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing

P. Parren, S. Verploegen, A. Labrijn, 2020, EBioMedicine.

Disappearance of factor VIII autoantibodies preceding autoimmune haemolytic anaemia

J. Voorberg, F. V. D. van der Meer, E. N. van den Brink, 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

Y. Guan, L. Poon, M. Peiris, 2008, PloS one.

HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate design

P. Parren, M. Peipp, T. Riedl, 2014, mAbs.

Analysis of factor VIII inhibitors in a haemophilia A patient with an Arg593→Cys mutation using phage display

J. Voorberg, M. Peters, P. Kaijen, 2002, British journal of haematology.

Longitudinal Analysis of Factor VIII Inhibitors in a Previously Untreated Mild Haemophilia A Patient with an Arg593→Cys Substitution

J. Voorberg, K. Fijnvandraat, E. N. van den Brink, 1999, Thrombosis and Haemostasis.

Phage Display Technology: A Tool to Explore the Diversity of Inhibitors to Blood Coagulation Factor VIII

J. Voorberg, E. N. van den Brink, 2000, Seminars in Thrombosis and Hemostasis.